Do other variables add value to assessment of the risk of colorectal disease using faecal immunochemical tests for haemoglobin?

Ann Clin Biochem. 2019 Jul;56(4):472-479. doi: 10.1177/0004563219839423. Epub 2019 May 2.

Authors

Jayne Digby¹, Robert Jc Steele¹, Judith A Strachan², Craig Mowat³, Annie S Anderson⁴, Rebecca McCann², Louise Law¹, Callum G Fraser¹

Affiliations

¹ 1 Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland.
² 2 Department of Blood Sciences, Ninewells Hospital and Medical School, Dundee, Scotland.
³ 3 Department of Gastroenterology, Ninewells Hospital and Medical School, Dundee, Scotland.
⁴ 4 Centre for Public Health Nutrition, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland.

PMID: 31037954
DOI: 10.1177/0004563219839423

No abstract available

Keywords: Bowel disease; colorectal disease; faecal biomarkers; faecal haemoglobin; faecal immunochemical test; primary care.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adenoma / diagnosis*
Adult
Aged
Aged, 80 and over
Colorectal Neoplasms / diagnosis*
Early Diagnosis
Female
Hemoglobins / analysis*
Humans
Inflammatory Bowel Diseases / diagnosis*
Male
Middle Aged
Occult Blood*
Primary Health Care / methods*

Substances

Hemoglobins

Grants and funding